💊Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device 2017年11月7日
💊Opdivo (nivolumab) Demonstrates Superior Three-Year Survival Benefit for Patients with Previously Treated Advanced Renal Cell Carcinoma (RCC)
👾Diabetes in China 〜 Publications / by Swiss Re
🔬RIKEN develops a technology to distinguish the interphase of the cell cycle (G1 · S · G2) by three colors 20171027
💊Takara Bio, launched quality test kit for products such as regenerative medicine